Celularity, Inc. CELU
1.38
0.06
4.55%
as of 25 Sep
- Market cap
- $38.2M
- P/E
- 0.0×
Follow CELU
| Older periods | Mar '25 | Jun '25 | Sep '25 | Dec '25 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(432.29%) | (6,367.24%) | 5,731.84% | 628.23% | |
| (40.80%) | (57.60%) | (66.35%) | (76.50%) | ||
ROIC |
(69.40%) | (172.59%) | (153.64%) | (1,070.92%) | |
Return on Tangible Assets |
(236.49%) | (1,098.23%) | (3,218.16%) | 726.09% | |
Average Days of Receivables |
107.20 | 91.29 | 60.31 | 63.97 | |
Free Cash Flow per Share |
(0.21) | (0.11) | (0.25) | (0.52) | |
Free Cash Flow |
(4.99) | (2.54) | (6.56) | (13.25) | |
Piotroski F-Score |
5.00 | 3.00 | 1.00 | 1.00 | |
| Other line items | |||||
Cash ROIC |
(13.16%) | (13.52%) | (32.81%) | (83.21%) | |
Accounts Receivable Turnover |
3.31 | 3.62 | 5.24 | 2.92 | |
Accounts Payable Turnover |
0.93 | 1.05 | 1.00 | 0.81 | |
Inventory Turnover |
3.42 | 5.47 | 6.14 | 6.71 | |
Average Days of Payables |
503.42 | 444.81 | 447.75 | 480.42 | |
Days of Inventory on Hand |
133.82 | 80.39 | 46.67 | 10.38 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
29.96% | 33.24% | 38.21% | 56.59% | |
Selling, General and Administrative Expense of Revenue |
115.52% | 124.70% | 128.79% | 193.09% | |
Share Based Compensation of Revenue |
22.05% | 23.99% | 24.81% | 39.09% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.09 | 0.03 | 0.08 | 0.14 | |
Depreciation/Fixed assets |
0.13 | 0.13 | 0.13 | 0.13 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
2.17 | 1.86 | 1.54 | 1.04 | |
Operating CF per Share |
(0.21) | (0.11) | (0.25) | (0.52) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(109.16%) | (165.21%) | (198.75%) | (345.76%) |
Columns are period end dates